Article thumbnail

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy

By Laura Lyons, Maha ElBeltagy, Jariya Umka, Rachel Markwick, Carla Startin, Geoffrey Bennett and Peter Wigmore
Topics: Original Investigation
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3072503
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 20:76–89 Taillibert
  2. (2007). Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial.
  3. (2001). Saykin A
  4. (2006). Systemic high-dose intravenous methotrexate for central nervous system metastases.
  5. (2002). The SSRIs drug fluoxetine, but not the noradrenergic tricyclic drug desipramine, improves memory performance during acute major depression. Brain Res Bull 58:345–350 Lledo